| CSP | AMA1 |
---|
Method | Assays | No. Positive | Cp1* | Assays | No. Positive | Ap7and9** |
---|
>Med. | 324 | 138 (42.6%) | 30/138 (21.7%) | 420 | 236 (56.2%) | 53/201 (26.3%) |
1
| 324 | 30 (9.3%) | 16/30 (53.0%) | 420 | 94 (22.4%) | 40/84 (47.6%) |
2
| 324 | 17 (5.2%) | 13/17 (76.5%) | 420 | 62 (14.8%) | 34/57 (60.0%) |
3
| 324 | 10 (3.1%) | 9/10 (90%) | 420 | 41 (9.8%) | 29/36 (80.1%) |
- ELISpot activities >medium controls were analysed using Methods 1, 2 and 3 (see Methods) and the positive activities for each method are shown. The numbers of Cp1 are for all volunteers tested, Ap7+Ap9 excluding v1001 who responded to different peptide pools. * Proportion of positive assays that are positive by Cp1; ** Proportion of positive assays that are positive by Ap7 or Ap9 excluding v1001.